Starting treatment in the first month after diagnosis increases the likelihood of blood pressure control with lasting ...

As a general rule, β-blockers should not be used as first-line treatment in patients with diabetes mellitus and hypertension due to unfavorable effect on endocrine metabolism. [31] However ...

Recently approved medications for resistant hypertension, uncomplicated UTIs and menopausal hot flashes show potential as ...

High blood pressure frequently occurs in people with diabetes. Learn about the relationship, risks, and treatments for ...

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

Aortic aneurysms — dangerous bulges in the body’s main artery, the aorta — are becoming increasingly common as more people ...

Improved hypertension control can save millions of lives, but mass hypertension screening, a commonly used approach, is a barrier to progress. Although politically appealing, mass screening diverts ...

Lorundrostat, a selective aldosterone synthase inhibitor, significantly reduced 24-hour systolic blood pressure in individuals with uncontrolled and treatment-resistant hypertension, according to ...

May 6, 2025 /PRNewswire/ -- PRM Pharma, LLC today announced the U.S. Food and Drug Administration (FDA) approval of HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in ...

HemiClor is expected to be available in pharmacies starting in May 2025. The Food and Drug Administration (FDA) has approved HemiClor ™, a low dose formulation of chlorthalidone, for the ...